Pharmaceutical Manufacturing of Albuterol Sulfate Inhalation Aerosol

The contract pertains to the manufacture and supply of FDA-compliant Albuterol Sulfate Inhalation Aerosol using HFA propellant, specifically designed for unit-dosed packaging and labeling in accordance with federal and military standards. The product must meet stringent regulatory requirements to ensure safety, efficacy, and consistency for use within the Department of Defense healthcare system. The manufacturing process, quality control, and packaging must adhere to all applicable pharmaceutical and defense guidelines to support reliable deployment across military medical channels. The solicitation is classified as a subcontract under NAICS code 325412, with the place of performance designated as Fort Stewart, Georgia, at zip code 31314-5185. The opportunity was posted on July 16, 2026, with a response deadline of July 22, 2026. While no specific set-aside classification or point of contact is listed, the agency overseeing the procurement is the Medical Supply Chain Pharm FSA under the Department of Defense. The contract emphasizes full compliance with federal pharmaceutical regulations and military logistics specifications, ensuring seamless integration into the defense supply chain for critical respiratory medication needs.